Developments in the clinical understanding of rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Developments in the clinical understanding of rheumatoid arthritis.

Developments in the clinical understanding of rheumatoid arthritis.

http://www.wikidata.org/entity/Q37207010

about

Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Predictors for half-year outcome of impairment in daily life for back pain patients referred for physiotherapy: a prospective observational study Exploring Tai Chi in rheumatoid arthritis: a quantitative and qualitative study.Effects of polysaccharide fractions isolated from Caltha palustris L. on the activity of phagocytic cells & humoral immune response in mice with collagen-induced arthritis: A comparison with methotrexate.Looking through the 'window of opportunity': is there a new paradigm of podiatry care on the horizon in early rheumatoid arthritis?Reduction in sickness absence in patients with rheumatoid arthritis receiving adalimumab: data from a German noninterventional study.Methotrexate ameliorates pristane-induced arthritis by decreasing IFN-γ and IL-17A expressions Targeting TNF-α and NF-κB activation by bee venom: role in suppressing adjuvant induced arthritis and methotrexate hepatotoxicity in rats.Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis.Thymoquinone inhibits TNF-α-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation.Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial Developments in the scientific understanding of rheumatoid arthritis.Interpreting clinical trial results for moderate-to-severe rheumatoid arthritis: practical applications for rheumatology healthcare providers.Effects of Apium graveolens Extract on the Oxidative Stress in the Liver of Adjuvant-Induced Arthritic Rats.Measuring metacarpal cortical bone by digital x-ray radiogrammetry: a step forward?Investigation of the kynurenine pathway in Indoleamine 2, 3 dioxygenase deficient mice with inflammatory arthritis.Validation of disease activity indices using the 28 joint counts in systemic sclerosis.Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment.

P2860

Q27687777-B9A1CB0D-8946-4D81-9A75-F4E15D215E02 Q28397092-37076857-E5FD-442E-95A2-65C6D4048FBA Q33537396-F969440E-D7DD-43B9-816F-ADC0C5694DF0 Q33882788-C0B70830-B83F-4608-9DDD-B5478EDE9091 Q33907217-5C6A1E07-0811-4AFD-9EEF-571630930F9C Q34114195-503FCF2A-93B8-42B7-8B2B-E62E96D23DF2 Q34473197-41EF09E5-B74F-4CC6-AF54-93F8AF8516CF Q35053154-C0EF3AAA-1669-4E34-9FD3-D2C6E6D98556 Q35146624-166A9B75-3777-4659-82AF-128C51262541 Q35995435-FC29F348-EC89-4CEA-8D7E-676C1C465F55 Q36098013-06E9200B-2EB1-4E42-AFA0-1FA0212527DF Q37454068-E2319D72-C88F-4D28-9688-A21A4200B36B Q37928726-7AE7B04E-788D-4574-9AD6-AB75AB61C2AA Q42430052-6C4275AD-8B47-4EC3-B924-9911DFF6F12F Q42692903-8DB9593F-416B-450C-AC15-9FD7F34C790C Q42970625-18264D15-FE35-475F-BE97-09AE06FAFC61 Q53067521-4A578853-D2A8-4F2B-BC03-20B19E025E6E Q53084304-C1CF8039-2684-43EA-9ADF-AC928E21EF7C

P2860

Developments in the clinical understanding of rheumatoid arthritis.

http://www.wikidata.org/entity/Q37207010

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Developments in the clinical understanding of rheumatoid arthritis.

@en

Developments in the clinical understanding of rheumatoid arthritis.

@nl

type

label

Developments in the clinical understanding of rheumatoid arthritis.

@en

Developments in the clinical understanding of rheumatoid arthritis.

@nl

prefLabel

Developments in the clinical understanding of rheumatoid arthritis.

@en

Developments in the clinical understanding of rheumatoid arthritis.

@nl

P1433

Q37207010-B13F14CB-1B13-4487-9042-2BB96D4B4199

P1476

Q37207010-0FC7C446-D243-4594-AF78-75CC4A29ADC2

P2093

Q37207010-FDDC8191-000C-4C6A-AB72-A218D7E5FDB0

P2860

Q37207010-0A368603-A2D0-412E-9C64-81B899C3B07B

Q37207010-0A67E913-FAF1-4690-BC6A-D96056E918EE

Q37207010-0CB6CE3A-8E94-4EB2-AA3B-3DC315B09943

Q37207010-105226E6-58FB-4F45-B3E2-D4C7D7E827F3

Q37207010-14A69DA8-6E42-47EA-9FFD-26ACD8B232C7

Q37207010-152F5BB9-FF3C-4A40-B498-DCCA8227007C

Q37207010-15650C95-FC57-4570-AB1F-76C979BF5A4F

Q37207010-163DCCD1-A32D-4191-A175-C991CB501B52

Q37207010-16694B8B-241E-4C3D-BE00-E14D861637A5

Q37207010-175A8132-6B7F-458A-87ED-DC538F27CE21

P2888

Q37207010-40A35517-9314-4F78-996E-32BB6F1E1210

P304

Q37207010-A5A71B89-ECF9-400C-A5E0-D408999EA01E

P31

Q37207010-1E6A1489-860C-41D3-9DAD-A23E967BDBF1

Q37207010-652C5DCD-FDA2-4BC7-A063-A1BC74E83DF6

P356

Q37207010-723A7292-C73F-402F-BB60-A42632B7421E

P433

Q37207010-FF06BCCD-DC9A-4947-9A3B-FB5FE36D46CB

P478

Q37207010-DBEE6B47-DAAB-46AF-A064-942A8984AE8C

P50

Q37207010-8C4E1729-23E5-47EB-B793-C5FEAD5AAA88

P577

Q37207010-F6CE7071-B5B7-4DA1-B9F7-2E5402B5641C

P5875

Q37207010-B11729ED-60C6-4D18-9A0F-2C58C1988AA0

P6179

Q37207010-44CE9D94-23ED-4E90-AD51-4E1A6DCE22F3

P698

Q37207010-556909FF-0070-46CA-BD4D-F27375C53712

P921

Q37207010-780CC8FA-AB55-4E88-90A5-63C750F91F0A

P932

Q37207010-0B3675A1-220C-4592-93FA-3D318CD95B7C

P356

P1433

Arthritis Research and Therapy

P1476

Developments in the clinical understanding of rheumatoid arthritis.

@en

P2093

Daniel Aletaha

http://www.w3.org/2001/XMLSchema#string

P2860

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score.

The MOS 36-ltem Short-Form Health Survey (SF-36)

C-reactive protein: a novel marker of cardiovascular risk

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

Evolving concepts of rheumatoid arthritis

How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.

Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with c

The definition and measurement of disease modification in inflammatory rheumatic diseases.

The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey.

P2888

P304

204

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR2535

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24029887

http://www.w3.org/2001/XMLSchema#string

P6179

1041606551

http://www.w3.org/2001/XMLSchema#string

P698

19232060

http://www.w3.org/2001/XMLSchema#string

P921

rheumatoid arthritis

P932

2688215

http://www.w3.org/2001/XMLSchema#string